Disability Timeline for Progressive MS
Links shared publicly online about this topic.
- 363total visits
Disability Timeline for Progressive MS
View full resource at disabled-world.com
Tags: Anxiety Disorder, Anxiety, Disability
Most Recently Shared on April 15, 2011 at 12:52 pm By:
Disability Timeline for Progressive MS http://ff.im/-BcKfe
Lifestyle study highlights key differences in relapsing and progressive onset MS
eurekalert.org — “Patients with relapsing onset multiple sclerosis who consumed alcohol, wine, coffee and fish on a regular basis took four to seven years longer to reach the point where they needed a walking aid than people who never consumed them. However, the study of 1,372 patients did not observe the same patterns in patients with progressive onset MS, suggesting that different mechanisms might be involved in how disability progresses in relapsing and progressive onset MS.” View full resource at eurekalert.org
Most Recently Shared on March 20, 2012 at 7:23 am By:
Lifestyle study highlights key differences in relapsing and progressive onset MS: (Wiley-Blackwell) Patients wit... http://t.co/JIjJEIy0
Drug Delays Disability in MS (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- The investigational oral multiple sclerosis drug laquinimod slows progression of disability and modestly reduces relapses in the relapsing-remitting form of the disease, researchers affirmed.” View full resource at qualitypointtech.net
Most Recently Shared on March 14, 2012 at 11:00 pm By:
Drug Delays Disability in MS (CME/CE): (MedPage Today) -- The investigational oral multiple sclerosis drug laquini... http://t.co/lHbnpn3W
Evaluating the Progression of MS: Physical Disability - Testing for MS - Multiple Sclerosis
healthcentral.com — “One of the dreaded words used in relation to multiple sclerosis is PROGRESSION. Much of what we do and hope for is a lack of disease progression over time.” View full resource at healthcentral.com
Most Recently Shared on November 28, 2011 at 2:05 pm By:
Evaluating the Progression of MS: Physical Disability - One of the dreaded words used in relation to multiple sclero... http://t.co/uAYp7p3s
Dimethyl Fumarate Considerably Reduces MS Relapses And Disability Progression
medicalnewstoday.com — “240 mg of Dimethyl Fumarate (BG-12) taken orally two or three times a day showed reduced relapses by about half in patients with relapsing-remitting multiple sclerosis (PRMS) compared to those on” View full resource at medicalnewstoday.com
Most Recently Shared on October 22, 2011 at 8:05 pm By:
Dimethyl Fumarate Considerably Reduces MS Relapses And Disability Progression http://t.co/7Xlw5TiI #multiplesclerosis
Oral BG-12 (Dimethyl Fumarate) Significantly Reduced Multiple Sclerosis (MS) Relapses and Disability Progression in Define Phase 3 Clinical Trial - Drugs.com MedNews
drugs.com — “240 mg of BG-12 Administered Either Twice or Three Times Oct 21, 2011 - Today Biogen Idec (NASDAQ BIIB) announced positive data from the Phase 3 DEFINE clinical” View full resource at drugs.com
Most Recently Shared on October 21, 2011 at 6:05 pm By:
Drugs and Devices OW OW Health
Oral BG-12 (Dimethyl Fumarate) Significantly Reduced Multiple Sclerosis (MS) Relapses and Disability Progr... http://t.co/jn7sS4EA #drug
Google to disable public sharing of private posts in Google+ [Updated] - latimes.com
latimesblogs.latimes.com — “Not even a week old, Google+ is still a work in progress, not yet opened up to the public, and will be receiving a few tweeks over the next week to curb a privacy loophole that has left some users a bit confused. A main feature of Google+ is the ability to share with set "Circles" of friends -- such as just co-workers, just family, or just old school buddies. But the privacy of sharing to Circles was called in to question earlier this week when it was discovered that anyone can share p” View full resource at latimesblogs.latimes.com
Most Recently Shared on July 2, 2011 at 12:47 am By:
Hisham Rana, MD Doctor and Physician
Commentary: Google to disable public sharing of private posts in Google+ [Updated] http://lat.ms/lP6qJZ
Survival in MS-based PML Improves, But Disability Still High (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Survival has improved dramatically for patients with multiple sclerosis who develop progressive multifocal leukoencephalopathy (PML) during treatment with natalizumab (Tysabri), a study found.” View full resource at qualitypointtech.net
Most Recently Shared on May 22, 2011 at 6:00 pm By:
Survival in MS-based PML Improves, But Disability Still High (CME/CE): (MedPage Today) -- Survival has improved dr... http://bit.ly/mAD2Tr
Medical News: Survival in MS-based PML Improves, But Disability Still High - in Neurology, General Neurology from MedPage Today
medpagetoday.com — “Survival has improved dramatically for patients with multiple sclerosis who develop progressive multifocal leukoencephalopathy (PML) during treatment with natalizumab (Tysabri), a study found.” View full resource at medpagetoday.com
Most Recently Shared on May 22, 2011 at 5:07 pm By:
Survival in MS-based PML Improves, But Disability Still High (CME/CE): (MedPage Today) -- Survival has improved dramat.. http://dld.bz/aaTgx
Oral Laquinimod Reduced MS Relapses by 23% : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on April 13, 2011 at 9:38 pm By:
Bob Finn - Medical News Net Health News
In MS, 2 yrs of laquinimod reduced relapse rate and disability progression. @SherryBoschert reports. http://bit.ly/ij1iS3
Mayo Clinic finds tool to predict disability timeline for progressive MS patients
physorg.com — “Many patients with progressive multiple sclerosis (MS) worry how quickly the disease will progress. Now, by noting the presence of certain markers in a commonly performed diagnostic test, Mayo Clinic researchers can predict whether patients will suffer a faster onset of disability and counsel them to ...” View full resource at physorg.com
Most Recently Shared on April 12, 2011 at 2:51 pm By:
PhysOrg Health News Health News
Mayo Clinic finds tool to predict disability timeline for progressive MS patients http://tw.physorg.com/221824270
Mayo Clinic Finds Tool to Predict Disability Timeline for Progressive MS Patients
newswise.com — “Many patients with progressive multiple sclerosis (MS) worry how quickly the disease will progress. Now, by noting the presence of certain markers in a commonly performed diagnostic test, Mayo Clinic researchers can predict whether patients will suffer a faster onset of disability and counsel them to help ease anxiety. The research is being presented at the American Academy of Neurology meeting in Honolulu, Hawaii.” View full resource at newswise.com
Most Recently Shared on April 12, 2011 at 2:27 pm By:
newswise Health Communicator and Health News
Mayo Clinic Finds Tool to Predict Disability Timeline for Progressive MS Patients: Many patients with progressiv... http://bit.ly/e2y1na
Cellcept For Multiple Sclerosis (Newest posts first) - The People's Medicine Community
prescriptiondrug-info.com — “cellcept was prescribed for me by neurologist for multiple sclerosis Have had MS for 20 years and had symptom progression 2 years ago Within 4 weeks I had almost complete turnaround with my MS disabilities I could see better was able to walk without my cane I could swallow without choking I speach a (Newest posts first)” View full resource at prescriptiondrug-info.com
Most Recently Shared on January 18, 2011 at 3:35 am By:
" i AM SO SCARED ! my dr prescribed to me friday. was on copaxone for 2 yrs then went to betaseron that didnt http://PD0.US/F185442
Questions to ask before choosing a therapy - Medbroadcast
medbroadcast.com — “1. Does the treatment alter the course of MS? Some treatments are only for reducing relapses; others are proven to reduce relapses and slow the progression of the disease. Interferon beta and natalizumab have been proven to slow the progression of the disease. Medication that alters the course of MS may help reduce the accumulation of permanent disability associated with the disease.” View full resource at medbroadcast.com
Most Recently Shared on December 1, 2010 at 2:24 pm By:
Questions to ask before choosing a therapy for multiple sclerosis (MS): http://bit.ly/f9uLUb
ECTRIMS: Early Alemtuzumab Still Works at Five Years (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- GOTHENBURG, Sweden -- Two annual treatments with alemtuzumab remain effective for at least five years in preventing disability progression in MS, though safety concerns remain.” View full resource at qualitypointtech.net
Most Recently Shared on October 15, 2010 at 8:49 pm By:
ECTRIMS: Early Alemtuzumab Still Works at Five Years (CME/CE): (MedPage Today) -- GOTHENBURG, Sweden -- Two annual... http://bit.ly/9skTgo
Advertisement
